questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Benzoates
Aminobenzoates
méta-Aminobenzoates
méta-Aminobenzoates : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication
Aminobenzoates
Tests de laboratoire
Aminobenzoates
Marqueurs biologiques
Toxicité
Évaluation clinique
Intoxication
Symptômes
5
Allergies
Réactions cutanées
Effets secondaires
Anaphylaxie
Prévention
5
Réglementations
Produits chimiques
Sécurité au travail
Équipements de protection
Sensibilisation
Campagnes d'information
Traitements
5
Antidotes
Traitement symptomatique
Réactions allergiques
Antihistaminiques
Suivi médical
Complications
Complications
5
Complications
Intoxication
Gestion des complications
Soins médicaux
Risques à long terme
Allergies
Facteurs de risque
5
Facteurs de risque
Travailleurs
Comportements à risque
Sécurité
Prédispositions génétiques
Sensibilité
Allergies
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "méta-Aminobenzoates : Questions médicales les plus fréquentes",
"headline": "méta-Aminobenzoates : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les méta-Aminobenzoates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-20",
"dateModified": "2025-03-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "méta-Aminobenzoates"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Aminobenzoates",
"url": "https://questionsmedicales.fr/mesh/D062365",
"about": {
"@type": "MedicalCondition",
"name": "Aminobenzoates",
"code": {
"@type": "MedicalCode",
"code": "D062365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.127.020"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "méta-Aminobenzoates",
"alternateName": "meta-Aminobenzoates",
"code": {
"@type": "MedicalCode",
"code": "D062368",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takayuki Katoh",
"url": "https://questionsmedicales.fr/author/Takayuki%20Katoh",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan."
}
},
{
"@type": "Person",
"name": "Hiroaki Suga",
"url": "https://questionsmedicales.fr/author/Hiroaki%20Suga",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan."
}
},
{
"@type": "Person",
"name": "Rashmi Kumar",
"url": "https://questionsmedicales.fr/author/Rashmi%20Kumar",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Department, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States."
}
},
{
"@type": "Person",
"name": "Hilkka I Kenttämaa",
"url": "https://questionsmedicales.fr/author/Hilkka%20I%20Kentt%C3%A4maa",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Department, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States."
}
},
{
"@type": "Person",
"name": "Bidisha R Bora",
"url": "https://questionsmedicales.fr/author/Bidisha%20R%20Bora",
"affiliation": {
"@type": "Organization",
"name": "Applied Organic Chemistry, Chemical Sciences & Technology Division, CSIR-North East Institute of Science and Technology, Jorhat-785006, AcSIR, Ghaziabad-201002, India. skgogoi1@gmail.com sanjibgogoi@neist.res.in."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Vertebral Compression Fractures.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36173908",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Open Surgical Treatments of Osteoporotic Vertebral Compression Fractures.",
"datePublished": "2023-08-16",
"url": "https://questionsmedicales.fr/article/37587622",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/os.13822"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vertebral compression fractures managed with brace: risk factors for progression.",
"datePublished": "2023-08-26",
"url": "https://questionsmedicales.fr/article/37632559",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00586-023-07905-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of the impact of underlying diseases in the elderly on postoperative re-fractures after osteoporotic compression fractures.",
"datePublished": "2024-09-11",
"url": "https://questionsmedicales.fr/article/39261867",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13018-024-04907-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Radiographic assessment of acute vs chronic vertebral compression fractures.",
"datePublished": "2022-10-22",
"url": "https://questionsmedicales.fr/article/36271261",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10140-022-02092-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Benzoates",
"item": "https://questionsmedicales.fr/mesh/D001565"
},
{
"@type": "ListItem",
"position": 8,
"name": "Aminobenzoates",
"item": "https://questionsmedicales.fr/mesh/D062365"
},
{
"@type": "ListItem",
"position": 9,
"name": "méta-Aminobenzoates",
"item": "https://questionsmedicales.fr/mesh/D062368"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : méta-Aminobenzoates - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur méta-Aminobenzoates",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur méta-Aminobenzoates",
"description": "Comment diagnostiquer une intoxication aux méta-Aminobenzoates ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une intoxication ?\nY a-t-il des marqueurs biologiques spécifiques ?\nComment évaluer la gravité de l'intoxication ?",
"url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Fractures,+Compression#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur méta-Aminobenzoates",
"description": "Quels sont les symptômes courants des méta-Aminobenzoates ?\nLes méta-Aminobenzoates causent-ils des allergies ?\nY a-t-il des effets secondaires graves ?\nComment les symptômes varient-ils selon la dose ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Fractures,+Compression#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur méta-Aminobenzoates",
"description": "Comment prévenir l'exposition aux méta-Aminobenzoates ?\nY a-t-il des réglementations sur leur utilisation ?\nQuels conseils de sécurité pour les travailleurs ?\nLes consommateurs doivent-ils être informés ?\nComment sensibiliser le public aux risques ?",
"url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Fractures,+Compression#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur méta-Aminobenzoates",
"description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les méta-Aminobenzoates ?\nComment gérer les réactions allergiques ?\nQuel suivi est nécessaire après traitement ?\nLes traitements sont-ils différents pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Fractures,+Compression#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur méta-Aminobenzoates",
"description": "Quelles complications peuvent survenir après une intoxication ?\nLes méta-Aminobenzoates peuvent-ils causer des cancers ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques à long terme ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Fractures,+Compression#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur méta-Aminobenzoates",
"description": "Qui est le plus à risque d'intoxication ?\nLes enfants sont-ils plus vulnérables ?\nQuels comportements augmentent le risque ?\nY a-t-il des prédispositions génétiques ?\nLes personnes allergiques sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D062368?mesh_terms=Fractures,+Compression#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux méta-Aminobenzoates ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour détecter les niveaux de méta-Aminobenzoates."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les concentrations de méta-Aminobenzoates."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges, des éruptions cutanées et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de marqueurs biologiques spécifiques, mais des tests de toxicité peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité de l'intoxication ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par l'intensité des symptômes et les résultats des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des méta-Aminobenzoates ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, des éruptions cutanées et des vertiges."
}
},
{
"@type": "Question",
"name": "Les méta-Aminobenzoates causent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des réactions allergiques, notamment des éruptions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires graves ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires graves peuvent inclure des troubles respiratoires et des réactions anaphylactiques."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon la dose ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes s'aggravent généralement avec l'augmentation de la dose et la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La plupart des symptômes sont réversibles avec un traitement approprié et l'élimination de l'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux méta-Aminobenzoates ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les produits contenant des méta-Aminobenzoates et suivez les consignes de sécurité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des réglementations sur leur utilisation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations existent pour limiter l'utilisation des méta-Aminobenzoates dans certains produits."
}
},
{
"@type": "Question",
"name": "Quels conseils de sécurité pour les travailleurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs doivent porter des équipements de protection et suivre des protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Les consommateurs doivent-ils être informés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'étiquetage des produits doit informer les consommateurs des risques potentiels."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le public aux risques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des formations peuvent sensibiliser le public aux risques associés."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal consiste à éliminer l'exposition et à administrer des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les méta-Aminobenzoates ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, mais des traitements symptomatiques peuvent être efficaces."
}
},
{
"@type": "Question",
"name": "Comment gérer les réactions allergiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent être traitées avec des antihistaminiques et des corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire après traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical est recommandé pour surveiller les symptômes et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent varier en fonction de l'âge et du poids de l'enfant."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une intoxication ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles respiratoires, des réactions allergiques sévères et des lésions organiques."
}
},
{
"@type": "Question",
"name": "Les méta-Aminobenzoates peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des soins médicaux appropriés et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des risques à long terme peuvent inclure des problèmes respiratoires chroniques et des allergies."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, surtout en cas d'exposition prolongée."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'intoxication ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs exposés à des produits chimiques contenant des méta-Aminobenzoates sont à risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables en raison de leur taille et de leur métabolisme."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage inapproprié de produits chimiques et le non-respect des consignes de sécurité augmentent le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines prédispositions génétiques peuvent influencer la sensibilité aux méta-Aminobenzoates."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus susceptibles de réagir."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Chemistry Department, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Chemistry Department, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Applied Organic Chemistry, Chemical Sciences & Technology Division, CSIR-North East Institute of Science and Technology, Jorhat-785006, AcSIR, Ghaziabad-201002, India. skgogoi1@gmail.com sanjibgogoi@neist.res.in.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry-Biochemistry and Physics, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry-Biochemistry and Physics, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Groupe de Recherche en Signalisation Cellulaire, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Groupe de Recherche en Signalisation Cellulaire, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Department of Medical Biology, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry-Biochemistry and Physics, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Groupe de Recherche en Signalisation Cellulaire, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry-Biochemistry and Physics, University of Québec at Trois-Rivières, Trois-Rivières, Québec, Canada.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
School of Life Sciences, Nantong University, Nantong, China.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Sterling Chemistry Laboratory, Yale University, New Haven, CT, 06520.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Sterling Chemistry Laboratory, Yale University, New Haven, CT, 06520.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Sterling Chemistry Laboratory, Yale University, New Haven, CT, 06520.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E, Minneapolis, MN 55455, United States.
Publications dans "méta-Aminobenzoates" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Atatürk University, Erzurum, 25240, Türkiye.
Publications dans "méta-Aminobenzoates" :
1 publication dans cette catégorie
Affiliations :
Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, Hradec Kralove 500 03, Czech Republic.
Publications dans "méta-Aminobenzoates" :
Fragility fractures, particularly in the hip and spine, are the most common complication of osteoporosis. In the US, approximately 1-1.5 million vertebral compression fractures (VCFs) occur annually. ...
With an aging population, the osteoporotic vertebral compression fracture (OVCF) has become a constant concern for its physical and neurological complications, such as spinal kyphosis and refractory p...
The aim of this study is to identify risk factors for vertebral compression fracture (VCF) progression in patients treated conservatively with a brace. Then, a case-control study was designed....
All patients over 50 years old with diagnosis of thoracic or lumbar VCF (T5 to L5) in absence of underlying oncological process, treated conservatively with brace, and consecutively attended at our de...
Five hundred and eighty-two consecutive patients were recorded. Incomplete follow-up excluded 74 patients and other 19 died in the first three months after diagnosis, so 489 cases were finally analyze...
Male gender, type A3 fracture of the AOSpine classification, thoracolumbar junction location, and incorrect use of the brace were identified as independent risk factors for VCF progression, which resu...
Postoperative refracture of osteoporotic compression fractures in the elderly due to underlying illnesses is a complicated matter involving several variables. A multidisciplinary approach involving or...
A retrospective analysis was conducted on 2383 patients between August 2013 and August 2023. 550 patients with comorbid geriatric underlying diseases were screened, 183 patients underwent refractories...
Among the patients gathered, the frequency of re-fracture was 33.3%. A statistically significant difference was observed when re-fracture was linked to patients with long-term alcohol consumption, ope...
Hypertensive disorders were protective factors against the formation of re-fracture, while alcohol intake usage for more than ten years, psychological abnormalities, scoliosis, chronic kidney disease,...
Distinguishing between acute and chronic vertebral compression fractures typically requires advanced imaging techniques such as magnetic resonance imaging (MRI). Recognizing specific radiographic find...
Patients with compression fractures that had both radiographic and MRI studies of the lumbar spine within a 30-day time frame were retrospectively reviewed. MRI studies were used to determine compress...
Sensitivity and specificity for radiographic reporting of acute fracture were 0.52 (95% CI: 0.42, 0.61) and 0.95 (95% CI: 0.93, 0.97) respectively. For chronic fractures, the sensitivity and specifici...
Radiographs are relatively insensitive in distinguishing between acute and chronic lumbar compression fractures but the presence of a subendplate cleft or subendplate density increases the likelihood ...
New vertebral compression fractures (NVCF) are common in patients with osteoporotic vertebral compression fractures (OVCF) who have undergone percutaneous vertebroplasty (PVP). We sought to develop a ...
New vertebral compression fracture (NVCF) occurring after bone cement injection in middle-aged and elderly patients with vertebral compression fracture is very common. Preoperative baseline characteri...
Retrospective analysis was performed for 200 patients who underwent bone cement injection (percutaneous kyphoplasty or vertebroplasty) for vertebral compression fractures between January 2019 and Janu...
Time from injury to surgery exceeding 7 days, low osteocalcin levels, elevated homocysteine levels, osteoporosis, mode of operation (percutaneous vertebroplasty), lack of postoperative anti-osteoporos...
This nomogram can effectively predict NVCF incidence after bone cement injection in middle-aged and elderly patients with vertebral compression fracture, thus aiding clinical decision-making and posto...
To evaluate the displacement in four lateral compression type 2 (LC2) fracture subtypes (iliac wing and three kinds of crescent fractures) and to investigate the appropriate closed reduction for treat...
A total of 71 patients with LC2 pelvic fractures from February 2014 to November 2019 were included in this retrospective cohort study. Preoperative X-ray and computed tomography data were used to asse...
A total of 13 iliac wing fractures (86.7%) and 16 Day type 1 fractures (94.1%) were vertically stable with only internal displacement, the ring width displacements were 5 (3, 8.75) and 8 (4, 12) mm, t...
LC2 fractures involve two different kinds of fracture displacement: internal displacement only and a combination of internal, cephalic, and dorsal dislocation through the sacroiliac joint. Good clinic...
Osteoporotic vertebral compression fracture (VCF) is the third most frequent fragility fracture in the world. Conservative treatment, vertebroplasty, and kyphoplasty are all recognized therapies. Howe...
All patients over 50 years old with a diagnosis of thoracic or lumbar VCF without underlying oncological process, treated conservatively or surgically, and consecutively attended at our department fro...
A total of 573 cases were selected for analysis. Most patients were treated conservatively (85.3%). Both groups were homogenous regarding epidemiological and clinical features. The median time elapsed...
Surgical treatment (vertebroplasty/kyphoplasty) of VCFs was associated with sooner pain relief without an increased risk of new or adjacent fractures. Moreover, the progression of treated fractures wa...
To investigate whether dynamic fracture mobility could affect the outcome of conservative treatment in patients with acute osteoporotic vertebral compression fracture (OVCF)....
A total of 158 patients who underwent conservative treatment in our hospital for painful OVCFs were included in this study and their data were retrospectively analyzed. According to the degree of pain...
The result showed that dynamic fracture mobility, overweight, age, and bone mineral density (BMD) (all P < 0.001) were independent factors influencing the outcome of conservative treatment. Receiver o...
This study confirmed that dynamic fracture mobility could be used as an independent factor predicting the outcome of conservative treatment in patients with acute OVCFs. It was also shown that overwei...